7-Bromo-4-methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine

Catalog No.: 
ACNBXS024
CAS No.: 
910037-14-8
Molecular Formula: 
C8H9BrN2O
Molecular Weight: 
229.08
7-Bromo-4-methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$52.00In stockInquiry
1g97%$128.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-4-methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
IUPAC Name7-bromo-4-methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
MDL No.MFCD09025911
Molecular FormulaC8H9BrN2O
Molecular Weight229.08
SMILESCN1C2=NC=C(Br)C=C2OCC1
InChI KeyKPGNYZHIKPSZMS-UHFFFAOYSA-N
Synonym7-BROMO-4-METHYL-3,4-DIHYDRO-2H-PYRIDO[3,2-B][1,4]OXAZINE;2H-Pyrido[3,2-b]-1,4-oxazine, 7-bromo-3,4-dihydro-4-methyl-
CAS No.910037-14-8
PubChem CID24229649

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACNBXS024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAHKT071 route compound structure diagram
    ACAHKT07134950-82-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNBXS024 route product structure diagram
    ACNBXS024910037-14-8In Stock
Inquiry

2. ACNBXS024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNBXS024 route product structure diagram
    ACNBXS024910037-14-8In Stock
Inquiry

3. ACNBXS024 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNBXS024 route product structure diagram
    ACNBXS024910037-14-8In Stock
Inquiry

Comments (0)